Abiopharma

Press Release: DiaMedica Therapeutics to Report Fourth Quarter 2025 Financial Results and Provide a Business Update March 31, 2026

Navigator Gas Announces Closing of Upsized Secondary Public Offering by Selling Shareholder and Concurrent Repurchase of Shares by Navigator Gas

DiaMedica Therapeutics to Report Fourth Quarter 2025 Financial Results and Provide a Business Update March 31, 2026

Quantum BioPharma Announces Peer-Reviewed Journal Publication of Groundbreaking Clinical Trial With Unbuzzd

Enlivex Receives Investigational New Drug (IND) Clearance from the FDA for Phase 2b Trial of Allocetra in AgeRelated Primary Moderate-to-Severe Knee Osteoarthriti

A New Press Release from Theriva Biologics, Inc.

Accenture Invests in DaVinci Commerce to Advance Agentic AI-Led Shopping

ORMAT TECHNOLOGIES, INC. ANNOUNCES CLOSING OF UPSIZED $1 BILLION CONVERTIBLE SENIOR NOTES OFFERING

FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Greenberg, Monica L.

FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Sabino, Anthony John